Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Suzhou Connect Biopharma Gains Rights to Arena’s Anti-Inflammatory Drugs

publication date: Jul 25, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Suzhou Connect Biopharmaceuticals, Ltd. gained control of two series of anti-inflammatory compounds from Arena Pharma of San Diego. Zheng Wei, PhD, initiated development of the compounds while he was Director of Immunology at Arena, and he is now Co-founder and CEO of Suzhou Connect. Terms of the agreement were not disclosed. More details....

Stock Symbol: (NSDQ: ARNA)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners